Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target refers to a **pseudogene**, a DNA sequence similar to the protein-coding gene PSMD12 but not believed to encode a functional protein product. Thus, it is not a therapeutic target and has no established biological role or disease relevance. The functional gene, PSMD12, encodes a non-ATPase subunit of the 19S regulatory complex of the 26S proteasome, critical for cellular protein degradation, but this description does **not** apply to the pseudogene[1][2][3]. **Key note:** - If your goal is to find information about therapeutic targets, you should look up the functional gene **"Proteasome 26S subunit, non-ATPase 12" (PSMD12, ENSG00000197170)** and **not the pseudogene**. - Pseudogenes, including "Proteasome 26S subunit, non-ATPase 12 pseudogene," generally lack established function, druggability, or disease association[1][2][3]. - The current target is not therapeutically actionable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome 26S subunit, non-ATPase 12 pseudogene.